IVF Department, IVIRMA Middle-East Fertility Clinic, Abu Dhabi, United Arab Emirates.
Department of Obstetrical, Women's University Hospital Tuebingen, Tübingen, Germany.
Front Endocrinol (Lausanne). 2020 May 15;11:307. doi: 10.3389/fendo.2020.00307. eCollection 2020.
The number of mature oocytes is a key factor in the success of Assisted Reproductive Techniques (ART). Exogenous gonadotropins are administered during ovarian stimulation in order to maximize the number of oocytes available for fertilization. During stimulation, monitoring is mandatory to evaluate individual response, to avoid treatment complications and assist in the determination of the optimal day for final oocyte maturation and oocyte retrieval. Routine monitoring during stimulation includes transvaginal ultrasound examinations and measurement of serum estradiol (E2). Due to multifollicular growth of follicles of varying size, serum E2 levels are commonly supraphysiological and often variable, rendering E2-measurement during ovarian stimulation unreliable as a determinant of oocyte maturity. In contrast to serum E2, serum Inhibin A levels increase once a minimum follicle size of 12-15 mm is achieved. Due to this fact, serum Inhibin A levels could present in combination with ultrasound monitoring a more reliable parameter to determine the optimal follicle size for final oocyte maturation, as only follicles with a size of 12 mm and beyond will contribute to the serum Inhibin A level. This prospective observational, cross-sectional study demonstrates, that on the day of final oocyte maturation serum Inhibin A is strongly correlated to the number of follicles ≥15 mm (0.72) and to the number of retrieved and mature oocytes (ρ 0.82/0.77, respectively), whereas serum E2 is moderately correlated to the parameters mentioned above (ρ 0.64/0.69/0.69, respectively). With an area under the curve (AUC) of 0.91 for Inhibin A, compared to an AUC of 0.84 for E2, Inhibin A can be regarded as a better predictor for the optimal timing of trigger medication with a threshold number of ≥10 mature oocytes. It can be concluded from this data that serum Inhibin A in combination with transvaginal ultrasound monitoring may be a more powerful tool in the decision making process on trigger timing as compared to E2.
成熟卵母细胞的数量是辅助生殖技术 (ART) 成功的关键因素。在卵巢刺激过程中会给予外源性促性腺激素,以最大限度地增加可用于受精的卵母细胞数量。在刺激过程中,为了评估个体反应、避免治疗并发症并协助确定最终卵母细胞成熟和卵母细胞采集的最佳日期,监测是强制性的。刺激期间的常规监测包括经阴道超声检查和血清雌二醇 (E2) 测量。由于卵泡大小不一的多卵泡生长,血清 E2 水平通常高于生理水平且经常变化,因此在卵巢刺激期间 E2 测量作为卵母细胞成熟的决定因素不可靠。与血清 E2 相反,一旦达到 12-15mm 的最小卵泡大小,血清抑制素 A 水平就会增加。由于这个事实,血清抑制素 A 水平与超声监测相结合,可以提供更可靠的参数来确定最终卵母细胞成熟的最佳卵泡大小,因为只有大小为 12mm 及以上的卵泡才会对血清抑制素 A 水平产生贡献。这项前瞻性观察性横断面研究表明,在最终卵母细胞成熟日,血清抑制素 A 与≥15mm 的卵泡数量(0.72)和取回的成熟卵母细胞数量(ρ 0.82/0.77)呈强相关,而血清 E2 与上述参数中度相关(ρ 0.64/0.69/0.69)。抑制素 A 的曲线下面积 (AUC) 为 0.91,而 E2 的 AUC 为 0.84,因此抑制素 A 可以被认为是触发药物最佳时机的更好预测指标,阈值为≥10 个成熟卵母细胞。根据这些数据可以得出结论,与 E2 相比,血清抑制素 A 与经阴道超声监测相结合可能是触发时机决策过程中的更有力工具。